Dalatic injection

Clindamycin USP

Composition:

Dalatic-300: Clindamycin USP 300mg Capsule.

Dalatic-300 Injection (IV/IM): Clindamycin USP 300mg/2ml Injection.

Dalatic-600 Injection (IV/IM): Clindamycin USP 600mg/4ml Injection.

Indications: Clindamycin is indicated in the treatment of the following infections casued by susceptible anaerobic bacteria or susceptible strains of gram positive bacteria such as streptococci, Pneumococci and staphylococci in Lower respiratory tract infections, skin and soft tissue infections, Bone and joint infections, Septicemia, Dental infections and also indicated for the treatment of AIDS associated Pneumonia.

Dosage and Adminstration: Dosage of Dalactic Capsule: Adult Patients: Serious infections: 150 to 300mg every 6 hours. More severe infections: 300 to 450mg every 6 hours. Pediatric Patients: Serious infections: 8 to 16mg/kg/day divided into three or four equal doses. More severe infections: 16 to 20mg/kg/day divided into three or four equal doses. To avoid the possibility of esophageal irritation, Clindamycin capsules should be taken with a full glass of water. In cases of β-hemolytic streptococcalinfections, treatment should continue for at least 10 days.

Dosage of Dalatic Injection (IV/IM): Adults: For Serious infections: 600-1200mg/day in 2-4 equal doses. More severe infections, 1200-2700 mg/day in 2-4 equal doses. For more Serious infections, these doses may have to be increased. Doses of as much as 4800 mg daily have been given intravenously to adults.

For Detail Please see PDF File.

Use in pregnancy & lactation: Pregnancy category B.

Packing: Dalatic-300: 2 x 7’s capsules in blister pack.

Dalatic-300 Injection (IV/IM): 1 x 5’s ampoules in blister pack.

Dalatic-600 Injection (IV/IM): 1 x 3’s ampoules in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.